Home Newsletters Human Immunology News Targeting Myeloid Derived Suppressor Cells Reverts Immune Suppression and Sensitizes BRAF-Mutant Papillary...

Targeting Myeloid Derived Suppressor Cells Reverts Immune Suppression and Sensitizes BRAF-Mutant Papillary Thyroid Cancer to MAPK Inhibitors

By
Justin.choi
-
0
Scientists demonstrated that BRAFV600E promoted thyroid cancer development by increasing myeloid-derived suppressor cells penetrance.
[Nature Communications]

Sorry, but the selected Zotpress account can't be found.

Full Article

RELATED ARTICLES

Exit mobile version